Compare Abbott Laboratories (ABT) vs Etsy Inc (ETSY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Etsy Inc — how do they compare? Abbott Laboratories trades at $94.9 (market cap $166.94B), while Etsy Inc trades at $77.36 (market cap $7.36B). The key difference: Abbott Laboratories is far larger — about 22.7× Etsy Inc's market cap, and Abbott Laboratories pays a 2.63% dividend while Etsy Inc pays none. Which is the better fit depends on your goals.
| ABT | ETSY | |
|---|---|---|
Market Cap | $166.94B | $7.36B |
Sector | Health | Consumer Cyclical |
52-Week High | $136.62 | $79.66 |
52-Week Low | $82.57 | $44.05 |
Enterprise Value | $193.69B | $9.01B |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
ETSY trades at $77.59, up 0.81% today, with a bullish technical signal from moving averages and support at $74. The company reported three consecutive quarterly earnings beats, with Q1 2026 EPS of $0.89 beating expectations of $0.62 (Seeking Alpha, 2026-05-29). Revenue for 2025 was $2.88B, though net income declined to $163M. Analyst consensus is a Buy with a $70.79 price target, and recent news highlights growth in AI seller tools and buyer recovery momentum.
ETSY shows potential with strong profitability margins and positive cash flow trends, but faces risks from high debt and competitive pressures. The stock's valuation multiples like P/E of 28.76 suggest moderate premium, while institutional sentiment remains cautiously optimistic amid execution challenges in sustaining growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Etsy Inc
Etsy operates a top-10 e-commerce marketplace operator in the U.S. and the U.K., with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $13.5 billion in 2021 consolidated gross merchandise volume, the firm has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. As of the end of 2021, the firm connected more than 96 million buyers and more than 7.5 million sellers on its marketplace properties: Etsy, Reverb (musical equipment), Elo7 (crafts in Brazil), and Depop (clothing resale).
Read more on ETSY →
